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Significance	of	Pathophysiology	
								“Polycys)c	ovary	syndrome	(PCOS)	affects	
8-10	percent	of	reproduc)ve-aged	females,	
making	it	the	most	common	state	of	
endocrine	dysfunc)on	in	women”	(Thornton	
et	al.,	2015).		Diagnosis	is	some)mes	missed	
or	delayed	because	pa)ents	with	PCOS	are	
oLen	treated	for	the	signs	and	symptoms	of	
the	condi)on	without	considera)on	for	the	
underlying	syndrome.		Many	pa)ents	receive	
treatments	for	their	specific	complaints	
before	they	are	further	evaluated	for	other	
poten)al	e)ologies	of	said	complaints,	which	
delays	diagnosis	and	treatment	and	also	
causes	frustra)on	for	the	pa)ent.		Some	very	
serious	co-morbidi)es	oLen	accompany	this	
syndrome,	including	glucose	intolerance,	
hypertension,	and	hyperlipidemia	and	it	is	
impera)ve	that	the	healthcare	provider	
recognize	and	address	these	issues	
(Thornton	et	al.,	2017).		
	O6erbein	University,	Westerville,	Ohio 		
Conclusions	Introduc(on																	
The	nurse	should	suspect	PCOS	in	women	with/								
without	a	history	of	irregular	periods	with	
complaints	of	acne,	hirsu)sm,	alopecia,	acanthosis	
nigricans	and	metabolic	syndrome.		Other	
hyperandrogenic	states	must	be	ruled	out	prior	to	
diagnosis	of	PCOS.		Pa)ents	must	be	counseled	
about	the	long	dura)on	of	treatment,	which	
includes	lifestyle	modifica)ons	with	diet	and	
exercise.		The	pa)ent	needs	to	be	made	aware	of	
their	risk	for	glucose	intolerance,	Type	2	diabetes,	
hyperlipidemia,	and	heart	disease.		Addi)onal	
targeted	therapies	for	hirsu)sm,	oligomenorrhea,	
and	infer)lity	should	be	discussed.		It	is	also	
important	that	the	nurse	offers	emo)onal	support	
to	pa)ents	with	PCOS	and	screens	for	anxiety	and	
depression	(Madnani	et	al.,	2013).		
					Polycys)c	ovary	syndrome	(PCOS)	affects	8-10	percent	of	
reproduc)ve-aged	females.		“…PCOS	happens	when	a	woman's	
ovaries	or	adrenal	glands	produce	more	male	hormones	than	
normal.		PCOS	causes	cysts	(fluid-filled	sacs)	to	grow	on	the	
ovaries”	(Medline	Plus,	2017).		It	is	one	of	the	most	common	
diseases	of	endocrine	dysfunc)on	in	women,	but	diagnosis	is	
some)mes	missed	or	delayed	because	pa)ents	with	PCOS	are	
oLen	treated	for	the	signs	and	symptoms	of	the	condi)on	
without	considera)on	for	the	underlying	syndrome.		Pa)ents	
oLen	present	with	complaints	of	acne,	hair	loss,	hirsu)sm,	
irregular	vaginal	bleeding,	and	infer)lity.		Many	pa)ents	receive	
treatments	for	these	specific	complaints	before	they	are	further	
evaluated	for	other	poten)al	e)ologies	of	said	complaints	
(Thornton	et	al.,	2015).	
					The	keys	to	diagnosis	and	treatment	of	this	syndrome	lie	in	
the	provider’s	ability	to	understand	the	diagnos)c	criteria.		
Treatments	should	be	aimed	at	controlling	the	symptoms	and	
underlying	causes	of	the	syndrome	(Thornton	et	al.,	2015).		The	
prevalence	of	PCOS	is	increasing	in	frequency	and	correct	
diagnosis	and	treatment	are	important	because	this	disease	puts	
the	pa)ent	at	higher	risk	of	developing	certain	co-morbidi)es	
such	as	diabetes,	metabolic	syndrome,	heart	disease,	and	high	
blood	pressure	(Medline	Plus,	2017).		A	provider	should	be	able	
to	iden)fy	the	clinical	manifesta)ons	of	the	syndrome	and	u)lize	
treatments	to	decrease	hyperandrogenic	symptoms,	reduce	
underlying	metabolic	abnormali)es,	eliminate	endometrial	
hyperplasia	and	carcinoma,	and	improve	ovula)on	in	those	
pa)ents	who	suffer	infer)lity	(Thornton	et	al.,	2015).	
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					I	have	been	working	in	women’s	health	for	seven	
years	now	and	have	always	had	a	par)cular	interest	in	
women’s	health	issues,	par)cularly	the	topic	of	
polycys)c	ovary	syndrome.		Given	its	incidence	and	
poten)al	health	consequences,	it	is	important	for	the	
provider	to	be	educated	on	this	topic	and	consider	it	
among	possible	e)ologies	for	their	pa)ents’	
complaints.		This	will	allow	the	pa)ent	to	receive	
prompt,	appropriate	treatment.		Correct	diagnosis	will	
also	alert	the	provider	to	the	pa)ent’s	increased	
metabolic	and	cardiovascular	risks,	so	they	can	
monitor	the	pa)ent	more	closely	for	these.	
					The	exact	e)ology	and	pathophysiology	behind	
PCOS	is	not	well	understood,	but	the	disease	seems	to	
result	from	a	combina)on	of	reproduc)ve	and	
metabolic	abnormali)es.		This	leads	to	chronic	
hyperandrogenism	and	increased	estrogen	
concentra)on,	which	leads	to	a	loss	of	normal	
hormonal	feedback.		This,	in	turn,	leads	to	a	rise	in	the	
levels	of	circula)ng	LH,	FSH,	estradiol,	and	low	
progesterone	levels	(Thornton	et	al.,	2015).		Polycys)c	
ovary	syndrome	develops	when	an	overproduc)on	of	
male	hormones	causes	cysts	to	grow	on	a	woman’s	
ovaries.		A	gene)c	component	has	been	suspected,	
and	PCOS	is	more	common	in	women	who	have	a	
mother	or	sister	with	PCOS	(Medline	Plus,	2017).	
	
Signs	and	Symptoms	
					Symptoms	of	PCOS	are	typically	related	to	
anovula)on	and	hyperandrogenism.		Symptoms	
usually	appear	within	two	years	of	puberty.		Pa)ents	
typically	present	with	a	spectrum	of	complaints	
including	acne,	androgenic	hair	loss,	acanthosis	
nigricans,	hirsu)sm,	irregular	vaginal	bleeding,	
amenorrhea	and	infer)lity.		Many	of	these	pa)ents	
will	also	have	other	major	medical	comorbidi)es	
along	with	PCOS.		These	include	coronary	artery	
disease,	metabolic	syndrome	(approximately	50	
percent	of	these	pa)ents),	elevated	blood	pressure,	
and	hyperlipidemia	(Thornton	et	al.,	2015).	
	
					The	prevalence	of	PCOS	is	
increasing	in	frequency	and	it	
is	an	important	issue	to	
address	due	to	the	sequelae	
and	co-morbidi)es	associated	
with	this	diagnosis.		Providers	
should	be	able	to	iden)fy	the	
clinical	manifesta)ons	of	the	
syndrome,	apply	therapy	
based	on	the	pa)ent’s	goals	to	
decrease	symptoms,	reduce	
underlying	metabolic	
abnormali)es,	eliminate	
endometrial	hyperplasia	and	
carcinoma,	and	improve	
ovula)on	in	the	pa)ent	
seeking	pregnancy	(Thornton	
et	al.,	2017).		
					There	is	no	known	cure	for	
PCOS.		Long	term	medica)ons	
and	lifestyle	changes	are	
essen)al	for	a	successful	
outcome.		The	goals	of	
treatment	are	aimed	at	
reversing	the	signs	and	
symptoms	of	androgen	excess,	
ins)tu)ng	cyclic	menstrua)on,	
restoring	fer)lity,	and	
addressing	any	metabolic	or	
endocrine	disturbances.		
Management	of	the	disease	is	
through	the	combined,	
synchronous	efforts	of	a	
dermatologist,	endocrinologist,	
gynecologist,	nutri)onist,	and	
personal	trainer	(Madnani	et	
al.,	2013).	
